PharmaVOICE - 
January 2014
Purchase Issue

In Every Issue
Last Word
Building an Innovation Supply Chain Dr. Noubar Afeyan, managing partner [...]
By

Dr. Noubar Afeyan

Talent Pool
Talent Pool Pharma Pool Greg Barrett Dr. Glenn Gormley Daiichi [...]
By

Ann Grey

On the Calendar
The Calendar The 13th annual ePharma conference, Feb. 10-12, New?York [...]
By

Heather Hummel

PharmaTrax
Pharma Trax Sales, Marketing, and R&D?Trends Affecting the Healthcare Industry [...]
By

Denise Myshko

Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Deloitte Launches [...]
By

Denise Myshko

What’s New
New Healthcare-related Products, Services, and Companies Cooney/Waters and Russo Partners [...]
By

Ann Grey

Social Buzz
A collection of social media news, events, and strategies. SMS [...]
By

Taren Grom, Editor

UpFront
Awards… Moderna Named Global Growth Company Moderna Therapeutics, a company [...]
By

Denise Myshko

Letter from the Editor
Innovation is in the air 2014 2014 marks the year [...]
By

Taren Grom, Editor

On The Cover

Innovation Incubators
Robin Robinson As the industry looks for new avenues to fill its pipeline, the incubator model provides speed, innovation, and results. In November 2013, Wellspring Biosciences discovered small molecules that bind irreversibly to a common oncogenic mutant, K-Ras G12C, one of the most promising approaches to target K-Ras yet reported. The finding was facilitated by [...]
By

Robin Robinson

Features

The Rise of the Social Congress
Joanne Wunder Business Unit Head Ogilvy HealthPR, part of Ogilvy CommonHealth Worldwide What is the main draw of international medical congresses? Although some might say it is the robust scientific programs showcasing cutting-edge research, others would say it is the opportunity to exchange ideas and network with peers from across the globe. In either case, [...]
By

Joanne Wunder, Business Unit Head, Ogilvy HealthPR, part of Ogilvy CommonHealth Worldwide

The Socialization of Multichannel DTC Marketing
Sean Hartigan, Senior Vice President of Multichannel/Digital Strategy, Ogilvy CommonHealth, part of Ogilvy CommonHealth Worldwide There is a great deal of pontification and theorizing about the nature of social media marketing, but much of it’s just plain wrong. Twice as wrong when it comes to DTC marketing. Social media isn’t about the number of tweets [...]
By

Sean Hartigan, Senior Vice President of Multichannel/Digital Strategy, Ogivly CommonHealth, part of Ogilvy CommonHealth Worldwide

The Fierce Urgency of
The Fierce Urgency of “Why” Social Media and the pharmaceutical industry Sean Nicholson, Senior Director, Social Media, Intouch Solutions Inc. Most discussions regarding social media engagement in the pharma context start with the question of “how?” How can a brand properly monitor its Facebook page, or prove a social program’s ROI, or escape FDA scrutiny, [...]
By

Sean Nicholson, Senior Director, Social Media, Intouch Solutions, Inc.

SHOWCASE FEATURE: Social Media: Social Engagement
Pharma companies continue to struggle with how to be socially acceptable within an increasingly more mobile ecosystem. The growth of the mobile health (mHealth) industry is exploding. According to a new IDC Health Insights Report, clinical mobility spending in the United States is expected to grow from .9 billion in 2011 to .4 billion in [...]
By

Taren Grom, Editor

The Philippines: Global Pharma Appeal
With 14 of the top 20 pharma companies establishing manufacturing facilities in the Philippines, the country is clearly a go-to destination. The Philippines, an island nation in Southeast Asia, has a population of more than 95 million people, making it the 12th most populated country in the world. In 2012, the Philippine economy grew faster [...]
By

Kim Ribbink

C-Suite: Clinical Services
By Taren Grom We asked C-suite executives throughout the clinical services ecosystem to provide their insights on where the biggest opportunities for innovation for improving the drug development process lie, what the biggest barriers are, and identify a recent innovation that is improving the process. Wendel Barr CEO SynteractHCR Opportunities: I think there are several [...]
By

Taren Grom, Editor

Breakthrough Therapies: Become A Priority
Denise Myshko The FDA’s new breakthrough therapy designation pathway, which was launched in 2012, aims to streamline and speed development of products for life-threatening diseases. Many people with life-threatening diseases often have little options for treatment. Now the FDA is working with biopharmaceutical companies to address this gap with a new regulatory designation. The breakthrough [...]
By

Denise Myshko

ACA: A Data Sharing Imperative
Denise Myshko The sharing of data has become a critical success factor in the healthcare market under the Affordable Care Act The Affordable Care Act changes how healthcare data need to be collected, managed, and analyzed. Accountable care organizations, providers, and payers will require connections between complex information systems and analysis of large volumes of [...]
By

Denise Myshko

Risk-Based Monitoring: A New Way to Ensure Quality Data
Denise Myshko The FDA’s new guidance about monitoring provides for remote and risk-based monitoring, which offers a more thoughtful process. What started as a way to make sure data were accurate and reflected the original source, clinical trial monitoring has become time-consuming, expensive, and inefficient. Over the past two decades, the number and complexity of [...]
By

Denise Myshko

What’s in a Game? Better Health Outcomes
Gamification techniques are solving some of healthcare’s most serious problems. Every year, one in four American adults suffers from a diagnosable mental disorder, yet most of them go untreated because the majority of primary-care providers have received little training about mental health risk factors, symptoms, and treatment options. Although primary care providers are generally the [...]
By

Robin Robinson

FEEDBACK